Senolytic to optimise cellular aging
MOTS-c is studied as an exercise-mimicking signal, but in practice it is positioned as supportive
In the current study, glutathione treatment significantly decreased ferritin levels, but the mechanism behind the decrease remains unclear
The FDAs own language makes it clear: Compounded drugs containing BPC-157 may pose risk for immunogenicity and may have complexities with regard to peptide-related impurities and API characterization. In plain terms, the FDA is worried about shady, unregulated research-use-only peptides sold online not about what happens when BPC-157 is responsibly compounded, tested for purity, and dispensed under medical supervision
Tolerability (veterinary): Generally well tolerated in veterinary studies, with occasional mild injection-site reactions
2.17 TUNEL Cell or tissue sections were fixed with 4% paraformaldehyde at room temperature for 15 min, followed by three washes with phosphate-buffered saline (PBS)